Guru Ownership Trend
Guru Analysis for Capricor Therapeutics, Inc. (CAPR)
Capricor Therapeutics, Inc. (CAPR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $55.68 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $49.57 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 30.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Capricor Therapeutics, Inc. (CAPR)
Major holders include Steven Cohen ($53.1 M), Cliff Asness ($248,081). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.85 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $49.57 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CAPR. The total reported sell value was $108,658.09.
Yes, 0 managers opened new positions in CAPR, and 1 increased their existing holdings. The total reported buy value was $49.68 M.